share_log

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caissa Capital Management Ltd.(0%),Cambyz Golestaneh(0%)

SEC announcement ·  Jun 29, 2023 08:22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more